Categories
2021 COVID-19 Statistics Vaccine

Updates, Questions, Present, and Future

A lot changed in pandemic landscape last week.  This blog outlines those changes and highlights important unanswered questions.

  • The surge of delta virus infections continues across the country.  Several weeks ago, I announced that the pandemic is over.  That statement requires revision.  Maybe the pandemic of alpha virus was over then, but the epidemic of delta virus is here now.  Delta virus is the overwhelming variant in the U.S. with parts of the country (Florida, Hawaii, and Louisiana) experiencing their highest cases of the entire pandemic.  
  • Deaths are up, but still low.  Unfortunately, it’s no longer the case that deaths are at the lowest level of the pandemic.  Deaths have increased with the current surge of delta virus.  Although even one death is too many, it is reassuring to see that deaths are not at levels seen during the winter surge, and that deaths have increased at a lower rate than infections during the current surge.  As with the previous two surges, older individuals are at great risk than younger individuals.  Based on data from the CDC COVID Data Tracker, COVID-19 deaths per ten million Americans during the week of July 24, 2021, were:  
    • 2 for individuals between 18 and 29 years-old
    • 5 for individuals between 30 and 39 years-old
    • 14 for individuals between 40 and 49 years-old
    • 22 for individuals between 50 and 64 years-old
    • 39 for individuals between 65 and 74 years-old
    • 101 for individuals aged 75 years and older.
  • New testing recommendations for COVID vaccinated individuals.  The CDC has changed its testing recommendations for vaccinated individuals who have had an exposure to someone with SARS-CoV-2 infection.  An exposure is still defined as contact of less than 6 feet for more than 15 minutes when one or both individuals are not wearing a mask.  Before this change, COVID vaccinated individuals were asked to test only if symptoms developed.  Now a SARS-CoV-2 test is recommended for COVID vaccinated individuals 3 to 5 days after the exposure, and the exposed individual should wear a mask indoors for up to 14 days until a negative result is obtained.

As individuals decide how to mitigate personal risk of death from COVID-19, the following information on the CDC COVID Data Tracker would help people make better decisions:

  • Reinfection rates and deaths among previously infected individuals.  Contrary to CDC recommendations, I believe vaccination of COVID survivors is a risk without benefit.  We could know the answer for sure if cases and deaths in the CDC COVID Data Tracker were stratified by previous infection status.  If unvaccinated people with previous infections have low infection and death rates, we could conclude that previous infection provides protection from COVID-19. 
  • Infection rates and deaths among previously vaccinated individuals.  This data exists, but not on the CDC COVID Data Tracker.   We could have a better understanding of the risk of breakthrough and serious disease if the CDC compiled and published this information beside the other important and helpful information on its website.
  • Vaccination complication rates by age and severity.  This information is essential to a risk/benefit analysis of COVID vaccination, but this data is especially difficult to compile for several reasons.  First, not all adverse effects report on VAERS are truly vaccine related.  Second, not all vaccine related adverse effects are reported on VAERS.  Finally, not all adverse effects caused by vaccine are recognized as such.  Delayed effects may never be flagged as vaccine related.  It may take years to ever sort out this problem.  The best we can do now is look at the vaccine warnings (see PfizerModernaJanssen), including the warning that “additional adverse reactions, some of which may be serious, may become apparent with more widespread use”.  We must continue to expect unknown consequences.

We are in our second year of the pandemic, and we have some experience to help us understand what’s coming.  The U.S. is experiencing its third surge of SARS-CoV-2 infections.  The first surge was associated with the original form of the virus.  The second surge coincided with the replacement of the original form by alpha variant.  The current surge began as the wave of delta variant replaced alpha.  Will it be the case that a surge will be experienced time a more infectious variant replaces its predecessor?  Could be.

Categories
2020 Statistics Testing

Accuracy, Precision and Predictive Value

We want accurate tests, don’t we?  By that, don’t we mean that we want precise test results?  Well, not exactly.  Before we leave the subject of laboratory statistics, there are a few more words we need to learn.

Accuracy is the ability of a test to aim for the target.  Visually, accuracy looks like this:

Icon

Description automatically generated

Even though none of the shots hits the bullseye, we can tell where the shooter is aiming.

Precision is the ability of a test to get the same answer repeatedly, illustrated like this:

A picture containing circle

Description automatically generated

Even though none of the shots hits the bullseye, all of the shots go to the same spot.

Putting these terms together, we can describe different aspects test performance.  Poor accuracy and poor precision look like this:

Icon

Description automatically generated

The shots are not centered on the bullseye, and they do not hit the same spot.  Together, favorable accuracy and precision can be illustrated like this:

A picture containing icon

Description automatically generated

All the shots hit the bullseye, repeatedly.  This is what an accurate and precise test looks like, too.  Accuracy and precision are both desirable but different aspects of test systems.

But are accuracy, precision, sensitivity and specificity enough to interpret tests?  Consider the case where these aspects of a test system are optimized.  In other words, the test is highly accurate, precise, sensitive and specific.  But what if the condition being tested for is not prevalent in the tested population.  Prevalence is the percentage of people in a given population who have the condition of a positive test.  Consider a test is 99.99% specific.  That means that for every 10,000 results, there is only 1 false positive.  But let’s say that the condition exists in the population at a rate of only 1 per 10,000 individuals.  In other words, out of 10,000 results, there is only one true positive result.  But we’ve already said that out of 10,000 tests, there will be one false positive result.  Therefore, if we get a positive result, there a 50% chance it’s the false positive, not the true positive.  That is what is meant by the term positive predictive value.   

Both positive and negative predictive values can be measured.  These are expressed mathematically as PPV = TP / (TP + FP) and NPV = TN / (TN + FN), respectively.  It’s okay to skip the math; just remember that predictive values are dependent on the prevalence of the condition; sensitivity and specificity are not.

Predictive value is important for test interpretation but should not be used for test selection.  Instead, sensitivity, specificity, accuracy and precision should be used to guide appropriate test selection.  These are the terms by which test systems are judged, and the key aspects of test performance analyzed by the FDA before tests are approved for use in the United States.

Categories
2020 Statistics Testing

Sensitivity and Specificity

We want tests that are highly sensitive and highly specific for the condition being tested, but that is not always possible.  Often, we must sacrifice one for the other.  Simply stated, negative results can be trusted when there is high sensitivity, and positive results can be trusted when there is high specificity.  So, we have to ask: is it better not to miss negatives or positives?  

There is not usually a neat separation between healthy patients and patients with disease.  Instead, patient populations exist in overlapping distributions, which can be illustrated as follows:

The vertical blue line represents the cutoff between positive and negative test results.  In this illustration, the cutoff is placed in a compromise position between the two populations, creating a group of false negatives (FN) and false positives (FP).  

Diagram

Description automatically generated

If a test is highly sensitive, the cutoff is shifted to the left, eliminating false negative results, but increasing the number of false positive results.

Diagram

Description automatically generated

If a test is highly specific, the cutoff is shifted to the right, eliminating false positive results, but increasing the number of false negatives.  As we have discussed previously, this is the situation with antigen tests for SARS-CoV-2. 

When screening large populations for disease, it is important not to miss possible positives, so we choose a test that highly sensitive.  We do not want any false negatives.  False positives can be sorted out later; this is just a screen after all.  On the other hand, it is important that confirmatory tests have high specificity.  When we are confirming disease in a population selected by a screen, we want to eliminate false positives.

If the goal of testing for SARS-CoV-2 is to avoid false negative results, favor sensitivity over specificity.  But this trade-off is not necessary with all test systems.  PCR tests increase sensitivity by amplification and increase specificity with detection probes unique to the virus.  The result is a separation between populations, increasing specificity and sensitivity at the same time:

Diagram

Description automatically generated

Are sensitivity and specificity the only considerations when evaluating a test?  No, it is more complicated, but I am sure you guessed that.  We will talk about other measures of test systems and the results they produce next time.

Categories
2020 COVID-19 Statistics Testing

Choosing Tests

The limits of my language mean the limits of my world.
-Ludwig Wittgenstein, 1918.

Throughout the pandemic of 2020, the vocabulary of laboratory medicine has been used indiscriminately and imprecisely, resulting in muddled communication and poor decisions.  Today we will discuss basic terms used to evaluate laboratory tests so that you can address these issues confidently and intelligently.

Reduced to its simplest possible terms, tests are measured by how good positive and negative results correlate to the presence or absence of the condition being tested.  Tests are either positive or negative, and patients either have the condition or not.  True positive results match a positive patient condition; false positive results are positive even though the patient does not have the condition.  Similarly, true negative results match a negative patient condition, and false negative results are negative even when the patient has the condition.  We can visualize these terms with a simple matrix:

Diagram, table

Description automatically generated

In the case of COVID-19, laboratories test for the presence of SARS-CoV-2 in patients who may or may not be infected by the virus.  Using this example, we can rewrite the matrix:

Diagram, table

Description automatically generated

Adding the number of true positives and false negatives, you get the number of infected patients.  Similarly, the number of uninfected patients is the false positives plus true negatives.  Sensitivity, the measure of the test’s ability to detect infection, is the number of true positives divided by the number of infected patients: TP/(TP+FN).  Sensitivity is low when there are many false negatives, but it gets close to 100% when false negatives are rare.  A highly sensitive test system minimizes false negatives; when the test result is negative, you can believe it is true.

Specificity is the measure of the test’s ability to detect nothing but infection, is the number of true negatives divided by the number of uninfected patients TN/(TN+FP).  Specificity is low when there are many false positives, but it gets close to 100% when false positives are rare.  A highly specific test system minimizes false positives; when the test result is positive, you can believe it is true.  Obviously, good test systems aspire to be both highly sensitive and specific, but like so many things in life, having both at once is often impossible.  Trade-offs are inevitable.  So how do we decide which is more important?  We will discuss that next time.